Reproducible Cells and Organoids via Directed- Differentiation Encoding | 20 541

Opportunity Information: Apply for 20 541

The NSF opportunity "Reproducible Cells and Organoids via Directed-Differentiation Encoding" (Funding Opportunity Number 20-541) is a research grant program run through NSF's Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET). It targets a central bottleneck in modern bioengineering and regenerative medicine: the fact that researchers can often coax stem or other undifferentiated cells toward specialized fates, but still cannot do so in a truly deterministic, controllable, and reproducible way across labs, batches, and conditions. The core aim is to move beyond ad hoc differentiation recipes and toward a rigorous, generalizable framework that explains how differentiation works and then uses that understanding to reliably produce mature, functional cells or organoids with pre-specified properties.

Projects are expected to do two things at once: deepen fundamental understanding of developmental processes and translate that understanding into practical, end-to-end differentiation strategies. NSF is explicitly looking for teams that can uncover mechanisms and molecular machinery involved in cell development, including the dynamics of regulatory networks and the role of cell-cell interactions, and then leverage those insights to purposefully manipulate cell fate. In practical terms, responsive proposals should build a "design rules" approach to differentiation, supported by predictive models and paired with methods for real-time sensing, active control, and quality assurance. The emphasis on sensing and control signals that NSF wants approaches that can monitor differentiation as it happens, detect deviations, and correct course rather than simply applying a static protocol and checking the outcome at the end.

A defining feature of the solicitation is its focus on reproducibility and encoding differentiation as an engineered, controllable process. Differentiation is framed as a complex, multiplex system involving signaling molecules, receptors, promoters, markers, and regulators that interact over time. While the field has identified many individual cues that influence lineage decisions, the program statement highlights that we still lack the ability to synthetically induce differentiation along a predetermined trajectory that can be actively monitored and manipulated "on-the-fly." This opportunity is meant to close that gap by supporting research that treats differentiation more like a controllable system: measurable state variables, predictive models of state transitions, feedback or feedforward control strategies, and standardized quality metrics that can yield consistent functional outcomes.

NSF also positions this program as aligned with its broader "Understanding the Rules of Life (URoL): Predicting Phenotype" investment, which is about predicting phenotype from genotype and environment. Here, that theme is applied specifically to intentionally guiding an undifferentiated cell toward a desired phenotype (a mature cell type, organoid, or tissue) with predetermined functions. In other words, proposals should not just show that a certain set of cues can produce a cell type; they should contribute to a more general capability to predict and drive cell fate outcomes based on measurable inputs and system behavior.

The solicitation is deliberately broad about biological starting points and targets. Investigators may choose any undifferentiated cell type from any animal species and pursue any functional product with real-world relevance, including individual specialized cells, organoids, or other living constructs. At the same time, NSF draws a clear boundary around what is considered responsive: proposals that only address one narrow piece of the differentiation pipeline, or proposals that mainly aim to build a functional living product without improving mechanistic understanding of development, are not a good fit. The expectation is that successful projects will integrate multiple components (mechanism, modeling, sensing, control, QA) into a cohesive and workable differentiation strategy, not a collection of loosely related aims.

Because the scientific problems span many domains, NSF strongly encourages interdisciplinary teams. Relevant expertise areas mentioned include developmental biology, stem cell biology, cell biology, engineering, synthetic biology, systems biology, computation, sensing, and physics. The structure of the funding reinforces that intent: the solicitation supports collaborative proposals with teams of three or more PIs/co-PIs and senior personnel, and it explicitly excludes single-PI proposals or a single PI plus only one other senior person. The program is designed for thoughtful, planned collaboration, which is also why a Letter of Intent is required before submitting the full proposal.

In terms of award parameters, projects may run up to four years, with budgets expected in the range of $1,000,000 to $1,500,000 (with a stated award ceiling of $1,500,000). Budgets must be justified by the scope of work and the need for complementary expertise across the collaboration. NSF anticipated making around five awards under this call. The original timeline listed a creation date of February 1, 2020 and an original closing date of April 30, 2020.

Overall, the opportunity is aimed at teams that can turn cell differentiation into a reproducible, engineerable process by combining deep mechanistic biology with quantitative prediction, real-time measurement, and control. NSF is signaling interest in foundational advances that would enable reliable production of functional cells and organoids at scale, with major downstream relevance to individualized and regenerative medicine, engineered immune or "killer" cell therapies for cancer, disease modeling and treatment, environmental monitoring and adaptive sensing, and the widespread use of 3D organoids as reproducible platforms for drug testing.

• The National Science Foundation in the science and technology and other research and development sector is offering a public funding opportunity titled "Reproducible Cells and Organoids via Directed- Differentiation Encoding" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 47.041.
• This funding opportunity was created on Feb 01, 2020.
• Applicants must submit their applications by Apr 30, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
• The number of recipients for this funding is limited to 5 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for 20 541

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: